{"id":11423,"date":"2025-07-26T19:56:01","date_gmt":"2025-07-26T17:56:01","guid":{"rendered":"https:\/\/valintermed.com\/?p=11423"},"modified":"2025-07-26T19:56:01","modified_gmt":"2025-07-26T17:56:01","slug":"sindrom-grehema-littla-pikkardi-lassyuera","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/sindrom-grehema-littla-pikkardi-lassyuera\/","title":{"rendered":"Graham-Little-Piccardi-Lassuer syndrome"},"content":{"rendered":"<div class=\"fpm_start\"><\/div>\n<p>Graham-Little-Piccardi-Lassuer syndrome (GLPL) is a rare, inherited disorder characterized by a combination of hypotrichosis (lack of skin hair) and painful sensitivity to the sun, which attracts attention to the cosmetic and medical aspects of the pathology. This syndrome was first described in the early 20th century and has remained a mystery for scientists and practicing doctors ever since. Since the disease affects not only the hair but also other skin structures such as glands, it creates a number of medical challenges and difficulties in diagnosis and treatment. The complexity of this disease is that its manifestations can vary from patient to patient, which makes diagnosis even more difficult and requires highly qualified and experienced doctors.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_86 counter-flat ez-toc-counter ez-toc-light-blue ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Content<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewbox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewbox=\"0 0 24 24\" version=\"1.2\" baseprofile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 eztoc-toggle-hide-by-default' ><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/sindrom-grehema-littla-pikkardi-lassyuera\/#%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\" >History of the disease and interesting historical facts<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/sindrom-grehema-littla-pikkardi-lassyuera\/#%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\" >Epidemiology<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/sindrom-grehema-littla-pikkardi-lassyuera\/#%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\" >Genetic predisposition to this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/sindrom-grehema-littla-pikkardi-lassyuera\/#%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Risk factors for the development of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/sindrom-grehema-littla-pikkardi-lassyuera\/#%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Diagnosis of this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/sindrom-grehema-littla-pikkardi-lassyuera\/#%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\" >Treatment<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/sindrom-grehema-littla-pikkardi-lassyuera\/#%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >List of medications used to treat this disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/sindrom-grehema-littla-pikkardi-lassyuera\/#%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Disease monitoring<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/sindrom-grehema-littla-pikkardi-lassyuera\/#%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\" >Age-related features of the disease<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/sindrom-grehema-littla-pikkardi-lassyuera\/#%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\" >Questions and Answers<\/a><\/li><li class='ez-toc-page-1'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/valintermed.com\/en\/medlibrary\/sindrom-grehema-littla-pikkardi-lassyuera\/#%D0%A1%D0%BE%D0%B2%D0%B5%D1%82%D1%8B_%D0%BE%D1%82_%D0%B4%D0%BE%D0%BA%D1%82%D0%BE%D1%80%D0%B0_%D0%9E%D0%BB%D0%B5%D0%B3%D0%B0_%D0%9A%D0%BE%D1%80%D0%B6%D0%B8%D0%BA%D0%BE%D0%B2%D0%B0\" >Advice from Dr. Oleg Korzhikov<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"%D0%98%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%8F_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F_%D0%B8_%D0%B8%D0%BD%D1%82%D0%B5%D1%80%D0%B5%D1%81%D0%BD%D1%8B%D0%B5_%D0%B8%D1%81%D1%82%D0%BE%D1%80%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B8%D0%B5_%D1%84%D0%B0%D0%BA%D1%82%D1%8B\"><\/span>History of the disease and interesting historical facts<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Graham-Little-Piccardi-Lassuer syndrome was first described in 1930 by neurologist D. Graham and dermatologist H. Little. These studies were preceded by observations of cases of androgenetic alopecia, as well as various dermatoses manifesting in patients with similar symptoms. After the publication of these original descriptions, the syndrome received its name, and dermatologists, geneticists and epidemiologists began to show interest in it. In the following decades, many clinical studies were conducted that helped to identify not only the clinical manifestations of the disease, but also its possible genetic roots. Interestingly, despite the rarity of the disease, cases of GLPL have been registered on all continents, which also emphasizes its universality and the need to include it in routine studies of rare diseases.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%AD%D0%BF%D0%B8%D0%B4%D0%B5%D0%BC%D0%B8%D0%BE%D0%BB%D0%BE%D0%B3%D0%B8%D1%8F\"><\/span>Epidemiology<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Graham-Little-Piccardi-Lassuer syndrome is a rare disorder and its prevalence is difficult to accurately estimate. The incidence of the syndrome is estimated to be approximately 1-5 cases per 100,000 population. It is worth noting that the incidence may vary depending on the geographic region and ethnicity. In communities with a high degree of consort marriage, the incidence may be higher. Further research is needed to more accurately assess the disease, as many cases are not diagnosed due to a lack of awareness among health care professionals about the condition. Therefore, it is important to educate both physicians and the public about rare diseases to increase the chances of early diagnosis and, therefore, correct treatment.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%93%D0%B5%D0%BD%D0%B5%D1%82%D0%B8%D1%87%D0%B5%D1%81%D0%BA%D0%B0%D1%8F_%D0%BF%D1%80%D0%B5%D0%B4%D1%80%D0%B0%D1%81%D0%BF%D0%BE%D0%BB%D0%BE%D0%B6%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D1%8C_%D0%BA_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%BC%D1%83_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8E\"><\/span>Genetic predisposition to this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Genetic predisposition to Graham-Little-Piccardi-Lassuer syndrome has been established through the study of familial cases of the disease. Mutations have now been found in genes such as KRT17, which play a key role in the structure and function of hair, as well as in maintaining the integrity of the skin. These genes are responsible for the formation of keratin, a protein that is the main component of hair and skin. Mutations lead to abnormalities affecting hair growth and quality, which is the main hallmark of the disease. In addition, it has been found that the syndrome can be inherited in both autosomal dominant and autosomal recessive patterns, which also complicates genetic counseling for patients and their families. Research is ongoing, and science is currently seeking to find out if there are other potential genes associated with this condition.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A4%D0%B0%D0%BA%D1%82%D0%BE%D1%80%D1%8B_%D1%80%D0%B8%D1%81%D0%BA%D0%B0_%D0%B2%D0%BE%D0%B7%D0%BD%D0%B8%D0%BA%D0%BD%D0%BE%D0%B2%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Risk factors for the development of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Risk factors that contribute to the development of Graham-Little-Piccardi-Lassuer syndrome can be both genetic and exogenous. It should be noted:<\/p>\n<ul>\n<li><strong>Heredity:<\/strong> Having close relatives with similar symptoms increases the risk of developing the syndrome.<\/li>\n<li><strong>Floor:<\/strong> According to some data, women may be more susceptible to this condition than men.<\/li>\n<li><strong>Age:<\/strong> The disease can manifest itself in different age groups, but the peak of manifestation is observed in adolescence.<\/li>\n<li><strong>Environmental factors:<\/strong> Exposure of the skin to ultraviolet radiation may worsen symptoms or increase the risk of developing the disease.<\/li>\n<li><strong>Chemical factors:<\/strong> The use of certain cosmetics containing active chemical compounds may worsen the skin condition and lead to more pronounced symptoms.<\/li>\n<\/ul>\n<p>Thus, early diagnosis and identification of risk factors are important to prevent or mitigate the manifestations of the syndrome.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%94%D0%B8%D0%B0%D0%B3%D0%BD%D0%BE%D1%81%D1%82%D0%B8%D0%BA%D0%B0_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Diagnosis of this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Diagnosis of Graham-Little-Piccardi-Lassuer syndrome requires a comprehensive approach consisting of clinical assessment, laboratory tests and instrumental diagnostics.<\/p>\n<ul>\n<li><strong>Main symptoms:<\/strong> characterized by hair loss on the scalp and body, hypopigmentation of the skin, sensitivity to sunlight and possible skin rashes.<\/li>\n<li><strong>Laboratory tests:<\/strong> Hormonal tests, infectious disease tests and genetic tests help to rule out other pathologies and confirm the diagnosis.<\/li>\n<li><strong>Radiological examinations:<\/strong> In some cases, ultrasound and other imaging techniques may be used to evaluate the condition of the skin and subcutaneous tissues.<\/li>\n<li><strong>Other types of disease diagnostics:<\/strong> Dermoscopy may be useful for visualizing hair follicles and skin structure.<\/li>\n<li><strong>Differential diagnosis:<\/strong> It is necessary to exclude other types of alopecia and dermatitis, which requires careful monitoring of the patient and assessment of the clinical picture.<\/li>\n<\/ul>\n<p>This multi-level diagnostic structure allows the doctor to correctly interpret clinical data and develop further treatment tactics.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9B%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5\"><\/span>Treatment<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Treatment of Graham-Little-Piccardi-Lassuer syndrome requires an individual approach and may include:<\/p><script data-noptimize=\"\" data-wpfc-render=\"false\">\nfpm_start( \"true\" );\n<\/script>\n\n<ul>\n<li><strong>General treatment:<\/strong> You should focus on skin care, including using sunscreen and moisturizers to protect against UV rays.<\/li>\n<li><strong>Pharmacological treatment:<\/strong> Preparations containing corticosteroids can be used to reduce inflammation, as well as vitamin complexes to maintain healthy skin and hair.<\/li>\n<li><strong>Surgical treatment:<\/strong> In severe cases, hair transplantation may be considered, although this method requires discussion with the patient.<\/li>\n<li><strong>Other types of treatment:<\/strong> Physical therapy techniques such as laser therapy are used, which can help in restoring hair growth and improving skin condition.<\/li>\n<\/ul>\n<p>It is also important to involve psychologists in the treatment process, since the patient\u2019s condition can negatively affect his emotional background and quality of life.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A1%D0%BF%D0%B8%D1%81%D0%BE%D0%BA_%D0%BB%D0%B5%D0%BA%D0%B0%D1%80%D1%81%D1%82%D0%B2_%D0%BF%D1%80%D0%B8%D0%BC%D0%B5%D0%BD%D1%8F%D0%B5%D0%BC%D1%8B%D1%85_%D0%B4%D0%BB%D1%8F_%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D1%8F_%D0%B4%D0%B0%D0%BD%D0%BD%D0%BE%D0%B3%D0%BE_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>List of medications used to treat this disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The list of drugs that can be used to treat Graham-Little-Piccardi-Lassuer syndrome includes:<\/p>\n<ul>\n<li><strong>Corticosteroids:<\/strong> triamcinolone, betamethasone.<\/li>\n<li><strong>Immunomodulators:<\/strong> tacrolimus.<\/li>\n<li><strong>Vitamin complexes:<\/strong> biotin, vitamin B.<\/li>\n<li><strong>Medicines for local use:<\/strong> solutions for external use containing resorcinol or salicylic acid.<\/li>\n<\/ul>\n<p>These substances help control inflammation and improve the overall condition of the skin and hair.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%9C%D0%BE%D0%BD%D0%B8%D1%82%D0%BE%D1%80%D0%B8%D0%BD%D0%B3_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Disease monitoring<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Monitoring of patients with Graham-Little-Piccardi-Lassuer syndrome requires regular examinations. <\/p>\n<ul>\n<li><strong>Control stages:<\/strong> It is necessary to conduct control examinations every 3-6 months to assess the condition of the skin and hair, as well as the effectiveness of therapy.<\/li>\n<li><strong>Forecast:<\/strong> The prognosis of the disease varies depending on the severity of symptoms and the adequacy of treatment. In most cases, improvement in the condition of the skin and hair is possible with timely medical care.<\/li>\n<li><strong>Complications:<\/strong> Skin infections and secondary skin diseases are possible, so it is important to consult a specialist in a timely manner.<\/li>\n<\/ul>\n<p>Thus, monitoring the condition of patients helps to avoid complications and ensure a high quality of life.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%B7%D1%80%D0%B0%D1%81%D1%82%D0%BD%D1%8B%D0%B5_%D0%BE%D1%81%D0%BE%D0%B1%D0%B5%D0%BD%D0%BD%D0%BE%D1%81%D1%82%D0%B8_%D0%B7%D0%B0%D0%B1%D0%BE%D0%BB%D0%B5%D0%B2%D0%B0%D0%BD%D0%B8%D1%8F\"><\/span>Age-related features of the disease<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Graham-Little-Piccardi-Lassuer syndrome can occur in various age groups.<\/p>\n<ul>\n<li><strong>Childhood:<\/strong> manifestations of the syndrome may be less pronounced and, as a rule, require further observation and assessment of the child&#039;s growth and development.<\/li>\n<li><strong>Adolescence:<\/strong> During this period, symptoms become activated, which is associated with hormonal changes in the body.<\/li>\n<li><strong>Adulthood:<\/strong> Patients may experience psychological difficulties due to the external manifestations of the disease and the need for constant skin care.<\/li>\n<li><strong>Old age:<\/strong> The condition may worsen with the appearance of concomitant diseases, which requires special attention from doctors.<\/li>\n<\/ul>\n<p>Treatment in different age groups also requires an individual approach and consideration of the individual characteristics of the body.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"%D0%92%D0%BE%D0%BF%D1%80%D0%BE%D1%81%D1%8B_%D0%B8_%D0%BE%D1%82%D0%B2%D0%B5%D1%82%D1%8B\"><\/span>Questions and Answers<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>What is Graham-Little-Piccardi-Lassuer syndrome?<\/strong> It is a rare inherited disorder characterized by underdeveloped hair and increased sensitivity to sunlight.<\/li>\n<li><strong>What are the main symptoms of the syndrome?<\/strong> The main symptoms include moderate hair thinning, skin hypopigmentation, and sensitivity to sun radiation.<\/li>\n<li><strong>How is this syndrome diagnosed?<\/strong> Diagnosis includes clinical observations, laboratory tests and instrumental examinations of the skin.<\/li>\n<li><strong>Is it possible to completely cure the syndrome?<\/strong> There is no complete cure, but appropriate treatment can significantly improve the quality of life of patients.<\/li>\n<li><strong>What is the prognosis for patients with this syndrome?<\/strong> The prognosis varies, but with prompt diagnosis and treatment, patients can lead a normal life.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"%D0%A1%D0%BE%D0%B2%D0%B5%D1%82%D1%8B_%D0%BE%D1%82_%D0%B4%D0%BE%D0%BA%D1%82%D0%BE%D1%80%D0%B0_%D0%9E%D0%BB%D0%B5%D0%B3%D0%B0_%D0%9A%D0%BE%D1%80%D0%B6%D0%B8%D0%BA%D0%BE%D0%B2%D0%B0\"><\/span>Advice from Dr. Oleg Korzhikov<span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>With all of the above in mind, patients may have many questions about living with Graham-Little-Piccardi-Lassuer syndrome. <\/p>\n<p>\u2014 Use sunscreen regularly to minimize the risk of skin damage.<br \/>\n\u2014 Consult a specialist to select an individual therapy and maintain contact with your doctor.<br \/>\n\u2014 Do not neglect psychological support - it is important for improving your overall condition and quality of life.<br \/>\n\u2014 Learn to communicate with others about your illness to reduce internal anxiety and increase support. <\/p>\n<p>It is important to focus on communicating with your doctor and obtaining the most complete information about your health condition.<\/p>\n<div class=\"fpm_end\"><\/div>","protected":false},"excerpt":{"rendered":"<p>Graham-Little-Piccardi-Lassuer syndrome (GLPL) is a rare, inherited disorder characterized by a combination of hypotrichosis (lack of hair on the skin) and painful sensitivity to the sun,<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[298],"tags":[],"class_list":["post-11423","post","type-post","status-publish","format-standard","hentry","category-medlibrary"],"_links":{"self":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/11423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/comments?post=11423"}],"version-history":[{"count":1,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/11423\/revisions"}],"predecessor-version":[{"id":15792,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/posts\/11423\/revisions\/15792"}],"wp:attachment":[{"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/media?parent=11423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/categories?post=11423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/valintermed.com\/en\/wp-json\/wp\/v2\/tags?post=11423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}